We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Kromek Group Plc | KMK | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.30 | 4.80% | 6.55 | 12:57:39 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 6.25 | 6.25 | 6.55 | 6.55 | 6.25 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 30/4/2024 03:29 by ark87 Remeber that KMK started at 51p 12 years ago and back then Basu stated"Arnab Basu, CEO, commented: "We are delighted with our oversubscribed fundraising. After many years developing the business and our technology, Kromek is ready to begin harvesting value by seizing the opportunities to sell our technology and products into the medical imaging, security screening and nuclear detection markets." What went so wrong and how has Basu kept his job and such a nice wage? Wheres the accountability? |
Posted at 26/4/2024 04:08 by b00mb0y Yes. I agree. But a long way to go, yet, for my breakeven. Come on KMK! |
Posted at 25/4/2024 08:36 by citys2874 FABULOUS CONTRACT WIN TODAY FOR KMK AND STG .....NICE |
Posted at 09/3/2024 07:49 by croasdalelfc Polymer had 57m when the new loan was announced - now they have 84m which is the rest of the shares from CLNPolymer now has a material interest with 84m with 13% and are owed £5.5m by KMK |
Posted at 05/2/2024 11:30 by brynos KROMEK GROUP PLCReleased 10:17:36 05 February 2024 RNS Number : 0345C Kromek Group PLC 05 February 2024 5 February 2024 Kromek Group plc ("Kromek" or the "Company" or the "Group") Conversion of £1.5m of Convertible Loan Notes Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, announces that two holders of the convertible loan notes ("Loan Notes") issued in August 2022 have elected to convert them into new ordinary shares of 1 penny each in the Company ("Ordinary Shares") at conversion prices of 6.3 pence and 7.1 pence, per Ordinary Share. Including accrued interest, the Loan Note holders are converting £1,509,211 of debt into 23,639,520 new Ordinary Shares and accordingly these new Ordinary Shares have been issued and allotted by the board. The issue prices of 6.3 and 7.1 pence per new Ordinary Share represent the closing price of the Company's Ordinary Shares on AIM on 31 January 2024 and 2 February 2024, respectively, being the repayment date of the convertible loan note facilities. Application has been made for the 23,639,520 Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on or around 8.00 a.m. on 9 February 2024 ("Admission"). The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following Admission, the Company's issued share capital will consist of 623,886,340 Ordinary Shares, none of which are held in treasury. Accordingly, the figure of 623,886,340 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules. |
Posted at 30/1/2024 16:25 by mjneish QP, a question if you don't mind. Are you short on KMK? |
Posted at 23/1/2024 12:05 by 33mick Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, gives notice that it will be announcing its interim results for the six months ended 31 October 2023 on Tuesday 30 January 2024.Dr Arnab Basu, Chief Executive Officer, and Paul Farquhar, Chief Financial Officer, will be hosting a presentation for investors at 6pm GMT on Wednesday 31 January 2024 via webinar. |
Posted at 02/1/2024 12:18 by quepassa yes, thanks. that's the article but it's a paywall.I was reading the London South East BB for KMK and a poster there mentioned that there were some reader comments on the article. ?? a mystery. thanks anyway. |
Posted at 26/10/2023 00:10 by ark87 Do we think Simon thompson actually owns any shares? He has been tipping it all the way down from 20p. If he's legit and and buying his own tips, he should be down huge on his intial purchase and given his confidence he should have been topping up the whole way down.Yet, he shows no signs of the annoyance a legit holder would be be feeling. I'm going to guess he is in some way being paid for the incredible promotion job he giving KMK and does'nt own any KMK shares or maybe a small token holding. Not to be trusted and should be investigated... Just my opinion. |
Posted at 09/9/2023 22:26 by 33mick To put things in context and the short term (which it is )financing arrangements being hopefully sorted soon.Philips is a £4+ billion company that has been designing state of the art hi tech medical equipment and systems for longer than anyone's been alive reading this, if you look you will see Philips name has cropped up numerous times in Kmk past news releases and broker reports, they were working with kmk's US subsidiary EV Products who they took over 10 years ago. Analogic Corp a US privately owned company was sold 6 years ago for 1.1 bill dollars with est 500+ mil dollar annual revenues. Spectrum Dynamics the the first OEM to fully adopt Kmk's CZT into thier premier CT product are est to be valued at 50-100 mil dol. Plus the un-named new Asian 1.4 mil CZT SPECT imaging customer announced in May this year... these companies owners, CEO's, management ,design and development teams have thier money, reputations and future growth & profitability all firmly aligned and committed to using kmk's CZT gamma modules after years of collaboration in most cases. and I have no reason to doubt kmk's confident statements predicting the likes of Fuji medical, United Imaging and the others they are working with will not follow suit. But obviously AQC knows better! and presumably thinks all these bods have made a disastrous error of judgement. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
